Spectral AI (MDAI) Gains from Investment Securities (2021 - 2026)
Spectral AI (MDAI) posted Gains from Investment Securities of $1.0 million for Q1 2026, up 123.97% on a QoQ basis from -$4.2 million in Q4 2025, and up 123.56% year-over-year from $448202.1 in Q1 2025.
Spectral AI (MDAI) Gains from Investment Securities (2021 - 2026) Analysis & Trends
Spectral AI's Gains from Investment Securities history runs 6 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- Quarterly Gains from Investment Securities rose 123.56% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 401.5% YoY) and the FY2025 annual result came in at -$3.2 million, down 170.13% from the prior year.
- Gains from Investment Securities was $1.0 million for Q1 2026 at Spectral AI, up from -$4.2 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $5.4 million in Q2 2025 and bottomed at -$7.5 million in Q1 2022.
- A 5-year average of -$400390.7 and a median of -$22000.0 in 2022 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities jumped 9657.14% — and 2025, when it tumbled 21165.0%.
- Spectral AI's Gains from Investment Securities stood at -$7000.0 in 2022, then soared by 9657.14% to $669000.0 in 2023, then jumped by 699.85% to $5.4 million in 2024, then plunged by 178.13% to -$4.2 million in 2025, then surged by 123.97% to $1.0 million in 2026.
- Business Quant data shows MDAI's Gains from Investment Securities at $1.0 million in Q1 2026, -$4.2 million in Q4 2025, and -$264000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Spectral AI | 52.23 Mn | 40.58 Mn | 2.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | -4.18 Mn |
| Dec 31, 2025 | -4.18 Mn |
| Sep 30, 2025 | -264,000.00 |
| Sep 30, 2025 | -264,000.00 |
| Jun 30, 2025 | 5.45 Mn |
| Jun 30, 2025 | 5.45 Mn |
| Mar 31, 2025 | -4.25 Mn |
| Mar 31, 2025 | -4.25 Mn |
| Dec 31, 2024 | 5.35 Mn |
| Dec 31, 2024 | 5.35 Mn |
| Sep 30, 2024 | -350,000.00 |
| Sep 30, 2024 | -350,000.00 |
| Jun 30, 2024 | -348,000.00 |
| Jun 30, 2024 | -348,000.00 |
| Mar 31, 2024 | -20,000.00 |
| Mar 31, 2024 | -20,000.00 |
| Dec 31, 2023 | 669,000.00 |
| Dec 31, 2023 | 669,000.00 |